Prefilled syringes are gaining strong acceptance in the market as drug delivery systems for injectable drugs. They have become a preferred device for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week.
The global prefilled syringes market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global prefilled syringes market segmentation is based on product types (glass prefilled syringes, plastic prefilled syringes), therapeutics (arthritis, heparin, insulin, PCSK9 inhibitor, vaccine, others), design (single-chamber, dual-chamber, customized).
The global prefilled syringes market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global prefilled syringes market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market owning to ease of administration, ease of handling, reduced risk of cross contamination, and increasing demand for biologics. The glass prefilled syringes segment accounted for the largest share of global market both by revenue and volume as compared to plastic prefilled syringes segment. However, the market for plastic prefilled syringes is expected to grow at a higher rate during the forecast period 2017-2021. Geographically, Europe dominated the prefilled syringes market followed by North America and Asia Pacific region.
Major players operating in the global prefilled syringes market and included in this report are Aniline Corporation, AptarGroup, Inc., axter International, Inc., Becton, Dickinson & Company, Bespak, Consort Medical plc, Gerresheimer AG, Haselmeier AG, Medtronic plc, Nipro Corporation, Niulife Corporation, Schott AG, SHL Group, Stevanato Group, Vetter Pharma International GmbH, Weigao Group, West Pharmaceutical Services, Inc., and Ypsomed Holding AG.